Screener
Veracyte VCYT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash used in financing activities | (6,629) | (6,484) |
| Decrease in cash, cash equivalents and restricted cash | (99,375) | (52,940) |
| Effect of foreign currency on cash, cash equivalents and restricted cash | (58) | 74 |
| Net decrease in cash, cash equivalents and restricted cash | (99,433) | (52,866) |
| Cash, cash equivalents and restricted cash at beginning of period | 364,226 | 240,631 |
| Cash, cash equivalents and restricted cash at end of period | $264,793 | $187,765 |
| Supplementary cash flow information: | ||
| Purchases of property, plant and equipment included in accounts payable and accrued liability | $2,317 | $977 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's net change in cash?
- Veracyte (VCYT) reported net change in cash of -$99.43M in Q1 2026.
- How has Veracyte's net change in cash changed year-over-year?
- Veracyte's net change in cash decreased by 88.1% year-over-year, from -$52.87M to -$99.43M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Veracyte's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude